BC
Broadwood Capital Portfolio holdings
AUM
$1.53B
This Quarter Return
-11.69%
1 Year Return
+36.91%
3 Year Return
+67.63%
5 Year Return
+132.65%
10 Year Return
+697.91%
AUM
$1.96B
AUM Growth
+$1.96B
(-12%)
Cap. Flow
+$1.96M
Cap. Flow
% of AUM
0.1%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
1
Reduced
1
Closed
–
Top Buys
| 1 |
IMDX
Insight Molecular Diagnostics Inc. Common Stock
IMDX
|
$2.04M |
Top Sells
| 1 |
STAAR Surgical
STAA
|
$84.2K |
Sector Composition
| 1 | Healthcare | 64.43% |
| 2 | Consumer Staples | 21.09% |
| 3 | Industrials | 6.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
STAAR Surgical
STAA
$1.36B
| $1.11B | 56.77% | 8,663,584 -655 | -0% | -$84.2K |
|
2
Monster Beverage
MNST
$60.9B
| $414M | 21.09% | 4,656,488 | – | – |
|
3
iShares Russell 2000 ETF
IWM
$67B
| $151M | 7.7% | 690,000 | – | – |
|
4
Axon Enterprise
AXON
$58.7B
| $133M | 6.78% | 760,062 | – | – |
|
5
Lineage Cell Therapeutics
LCTX
$267M
| $85.7M | 4.37% | 34,005,379 | – | – |
|
|
IMDX
6
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$72.4M
| $61.8M | 3.15% | 17,349,945 +573,461 | +3% | +$2.04M |
|
7
Serina Therapeutics
SER
$54.5M
| $2.82M | 0.14% | 2,997,156 | – | – |
|